Cargando…
Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases
Denosumab is a commonly used antiresorptive treatment in patients with osteoporosis or solid tumours with bone metastases. Upon denosumab discontinuation, a rebound phenomenon can occur that results in an increased (vertebral) fracture risk. This phenomenon is well-known in the setting of osteoporos...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109183/ https://www.ncbi.nlm.nih.gov/pubmed/35585959 http://dx.doi.org/10.1016/j.bonr.2022.101582 |